Development
The Clorox Company
CLX
$122.17
$0.590.49%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 16.03% | -20.34% | 12.10% | 5.86% | 1.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.03% | -20.34% | 12.10% | 5.86% | 1.42% |
| Cost of Revenue | 2.65% | -24.39% | 2.29% | -3.88% | -3.35% |
| Gross Profit | 39.68% | -13.12% | 28.74% | 23.27% | 11.11% |
| SG&A Expenses | 16.44% | 1.88% | 18.30% | 32.39% | 6.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 40.00% | -36.36% | 150.00% | -37.50% | -66.67% |
| Total Operating Expenses | 6.53% | -17.12% | 7.95% | 5.16% | -0.89% |
| Operating Income | 112.34% | -52.87% | 53.33% | 10.86% | 32.76% |
| Income Before Tax | 4.62% | -75.00% | 83.72% | -222.50% | 39.78% |
| Income Tax Expenses | 42.86% | -86.21% | 124.00% | -175.00% | 33.33% |
| Earnings from Continuing Operations | -5.88% | -71.26% | 74.04% | -237.50% | 41.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00% | -50.00% | -66.67% | 0.00% | 0.00% |
| Net Income | -6.06% | -74.12% | 74.26% | -240.67% | 43.48% |
| EBIT | 112.34% | -52.87% | 53.33% | 10.86% | 32.76% |
| EBITDA | 81.13% | -36.62% | 42.52% | 9.71% | 23.98% |
| EPS Basic | -6.54% | -74.25% | 73.43% | -240.12% | 42.91% |
| Normalized Basic EPS | 122.71% | -63.62% | 75.23% | 10.24% | 45.93% |
| EPS Diluted | -6.39% | -75.00% | 72.47% | -241.32% | 42.86% |
| Normalized Diluted EPS | 122.69% | -63.64% | 74.86% | 10.88% | 46.39% |
| Average Basic Shares Outstanding | 0.51% | 0.51% | 0.48% | 0.38% | 0.39% |
| Average Diluted Shares Outstanding | 0.51% | 0.59% | 0.68% | -0.18% | 0.06% |
| Dividend Per Share | 1.69% | 1.69% | 1.69% | 1.72% | 1.72% |
| Payout Ratio | 0.09% | 2.97% | -0.41% | -1.73% | -0.29% |